NanoVibronix prices $2M registered direct offering of common stock and prefunded warrants at $7.01

ENvue Medical, Inc.

Offering of 74,114 common shares and prefunded warrants for 217,090 shares at $7.01 per share (or $7.009 per warrant).
Gross proceeds of ~$2.0M; net proceeds ~$1.8M after placement fees and expenses.
Proceeds to be used for working capital, repayment of debt and/or redemption of preferred stock.
Palladium Capital Group acted as exclusive placement agent; closing expected September 17, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.